Safety and Efficacy of Satralizumab in Patients with Generalized MG
Dr. Justin Abbatemarco and Dr. Aaron Zelikovich discuss the safety and efficacy of satralizumab and its role in the current treatment landscape for myasthenia gravis. Show reference
Read the full articleYou might also wanna read
EAN 2026: Positive trial data for cemdisiran underscores potential for use in generalized MG, says GlobalData
On June 30, at the 12th Congress of the European Academy of Neurology (EAN) 2026, Regeneron announced the results from an additional analysi
Megan’s Myasthenia Gravis Story: From Uncertainty to Advocacy
I was diagnosed with myasthenia gravis, or MG, in 2021 when I was in my early 20s. My journey began at a friend’s birthday party when I noti
Sexual and Urinary Dysfunctions in Generalized Myasthenia
Conditions : Myasthenia Gravis (MG) Interventions : Other: No intervetion Sponsors : Centre Hospitalier Universitaire de Nice Not yet recrui
Do You Need To Avoid Certain Medications When You Have Myasthenia Gravis?
Some medications and supplements can worsen MG symptoms — but the rules aren’t always set in stone
Real-world data point to patient experience as next battleground for anti-CD20 therapies in RMS, says GlobalData
As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on
Efficacy and Safety of Low-Dose Blinatumomab in the Treatment of Refractory Autoimmune Encephalitis and Autoimmune Cerebellitis
Conditions : Autoimmune Encephalitis (AE); Autoimmune Cerebellitis Interventions : Drug: Blinatumomab Sponsors : Beijing Tiantan Hospital No
Comments
Sign in to join the conversation.
No comments yet. Be the first.